Abstract:Due to the unique physiological barriers within the lungs, there are considerable challenges in developing drug delivery systems enabling prolonged drug exposure to respiratory epithelial cells. Here, we report a PulmoSphere-based dry powder technology that incorporates a drug-phospholipid complex to promote intracellular retention of dehydroandrographolide succinate (DAS) in respiratory epithelial cells following pulmonary delivery. The DAS-phospholipid complex has the ability to self-assemble into nanoparticles. After spray-drying to produce PulmoSphere microparticles loaded with the drug-phospholipid complex, the rehydrated microparticles discharge the phospholipid complex without altering its physicochemical properties. The microparticles containing the DAS-phospholipid complex exhibit remarkable aerodynamic properties with a fine particle fraction of ∼ 60% and a mass median aerodynamic diameter of ∼ 2.3 μm. These properties facilitate deposition in the alveolar region. In vitro cell culture and lung tissue explants experiments reveal that the drug-phospholipid complex prolongs intracellular residence time and lung tissue retention due to the slow intracellular disassociation of drug from the complex. Once deposited in the lungs, the DAS-phospholipid complex loaded microparticles increase and extend drug exposure to the lung tissues and the immune cells compared to the free DAS counterpart. The improved drug exposure to airway epithelial cells, but not immune cells, is related to a prolonged duration of pulmonary anti-inflammation at decreased doses in a mouse model of acute lung injury induced by lipopolysaccharide. Overall, the phospholipid complex loaded microparticles present a promising approach for improved treatment of respiratory diseases, e.g. pneumonia and acute respiratory distress syndrome.

Sophoridine-loaded PLGA Microspheres for Lung Targeting: Preparation, in Vitro, and in Vivo Evaluation

Aerosol delivery of biocompatible dihydroergotamine-loaded PLGA-PSPE polymeric micelles for efficient lung cancer therapy

Design of gefitinib-loaded PLGA microspheres via microfluidics for lung cancer

Inhalable Functional Mixed-Polymer Microspheres to Enhance Doxorubicin Release Behavior for Lung Cancer Treatment

Preparation and in Vitro Evaluation of Etoposide-Loaded PLGA Microspheres for Pulmonary Drug Delivery.

Preparation and Testing of Cefquinome-Loaded Poly Lactic-Co-glycolic Acid Microspheres for Lung Targeting.

Sophoridine Inhibits Lung Cancer Cell Growth and Enhances Cisplatin Sensitivity Through Activation of the P53 and Hippo Signaling Pathways.

Preparation,in vitro and in vivo evaluation of actively lung targetable microspheres for paclitaxel delivery

Docetaxel-Loaded Chitosan Microspheres As A Lung Targeted Drug Delivery System: In Vitro And In Vivo Evaluation

Synergistic co-delivery of doxorubicin and paclitaxel by porous PLGA microspheres for pulmonary inhalation treatment.

Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy

Inhalable microspheres embedding chitosan-coated PLGA nanoparticles for 2-methoxyestradiol.

Sophoridine Inhibits the Tumour Growth of Non-Small Lung Cancer by Inducing Macrophages M1 Polarisation via MAPK-Mediated Inflammatory Pathway

Studies on the Poly(lactic-Co-glycolic) Acid Microspheres of Cisplatin for Lung-Targeting.

Effect of Sizes on the Lung-Targeting and Biocompatibility of Intravenously Administered Biodegradable PLGA Microspheres

Inhalable spray-dried porous microparticles containing dehydroandrographolide succinate phospholipid complex capable of improving and prolonging pulmonary anti-inflammatory efficacy in mice

Sophoridine is a New Antitumor Medicine with New Molecular Structure

Monosized Polymeric Microspheres Designed for Passive Lung Targeting: Biodistribution and Pharmacokinetics after Intravenous Administration

Nanomicelle-Microsphere Composite as a Drug Carrier to Improve Lung-Targeting Specificity for Lung Cancer

Development and characterization of lung surfactant-coated polymer nanoparticles for pulmonary drug delivery

Development of Andrographolide Loaded PLGA Microspheres: Optimization, Characterization and in Vitro–in Vivo Correlation